These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect. Li L, Kang L, Zhao W, Feng Y, Liu W, Wang T, Mai H, Huang J, Chen S, Liang Y, Han J, Xu X, Ye Q. Cancer Lett; 2017 Aug 01; 400():89-98. PubMed ID: 28461244 [Abstract] [Full Text] [Related]
47. MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells. Li N, Yang L, Wang H, Yi T, Jia X, Chen C, Xu P. PLoS One; 2015 Aug 01; 10(6):e0128886. PubMed ID: 26043084 [Abstract] [Full Text] [Related]
50. Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1. Zhang Y, Ai H, Fan X, Chen S, Wang Y, Liu L. Biol Res; 2020 Apr 29; 53(1):18. PubMed ID: 32349783 [Abstract] [Full Text] [Related]
53. miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression. Xu X, Jin S, Ma Y, Fan Z, Yan Z, Li W, Song Q, You W, Lyu Z, Song Y, Shi P, Liu Y, Han X, Li L, Li Y, Liu Y, Ye Q. J Mol Med (Berl); 2017 Aug 29; 95(8):861-871. PubMed ID: 28487996 [Abstract] [Full Text] [Related]